On Wednesday, TASER International, Inc. (NASDAQ:TASR)’s shares declined -1.32% to $32.20.
TASER International (TASR) declared large orders of its Axon body-worn video cameras and Evidence.com solution, a back-end digital evidence administration system. These orders were received in the second quarter of 2015 and shipped in the second quarter or are predictable to ship in the third quarter of 2015.
Large orders were received from the following domestic agencies:
- Portsmouth Police Department (VA): 220 Axon Flex cameras with five years o f Evidence.com
- Montgomery County Police Department (MD): 160 Axon Flex and Body cameras with five years of Evidence.com and TASER Assurance Plan (TAP)
- Ventura Police Department (CA): 90 Axon Body cameras with five years of Evidence.com and TAP
- Kauai Police Department (HI): 105 Axon Flex cameras with five years of Evidence.com on the Officer Safety Plan
- Rochester Police Department (MN): 100 Axon Body cameras with three years of Evidence.com
- Gardena Police Department (CA): 100 Axon Flex cameras with five years of Evidence.com and TAP
- Pleasanton Police Department (CA): 86 Axon Flex cameras with five years o f Evidence.com and TAP
TASER International, Inc. develops, manufactures, and sells conducted electrical weapons (CEWs) worldwide. It operates through two segments, TASER Weapons and AXON. The companys CEW products transmit electrical pulses along the wires and into the body affecting the sensory and motor functions of the peripheral nervous system. It offers three hand-held CEW product lines, counting TASER X26P and TASER X2, which integrates with EVIDENCE.com; and TASER X26.
Astoria Financial Corp (NYSE:AF)’s shares gained 2.29% to $14.28.
Astoria Financial Corporation (AF) the holding company for Astoria Bank stated net income accessible to common shareholders of $29.2 million, or $0.29 diluted earnings per common share (“diluted EPS”), for the quarter ended June 30, 2015, contrast to net income accessible to common shareholders of $20.1 million, or $0.20 diluted EPS, for the quarter ended June 30, 2014. For the six months ended June 30, 2015, net income accessible to common shareholders totaled $46.4 million, or $0.46 diluted EPS contrast to $49.5 million, or $0.50 diluted EPS, for the comparable 2014 period. Comprised of in the 2015 second quarter and six month results is a reduction in income tax expense of $11.4 million ($0.11 per common share) related to the impact of income tax legislation enacted in the second quarter of 2015, primarily as applicable to New York City. Comprised of in the 2014 second quarter results was a $5.7 million loan loss release ($3.7 million or $0.04 per common share, after tax) resulting from the designation of non-performing residential mortgage loans as held-for-sale. Also comprised of in the 2014 six month results was a reduction in income tax expense of $11.5 million ($0.12 per common share) related to the impact of New York State income tax legislation enacted on March 31, 2014.
Astoria Financial Corporation operates as the holding company for Astoria Bank that provides various financial products and services to individuals and businesses in the United States. The company accepts various deposit products, counting passbook and statement savings accounts, money market accounts, NOW and demand deposit accounts, and certificates of deposit.
At the end of Wednesday’s trade, Total System Services, Inc. (NYSE:TSS)‘s shares dipped -0.71% to $44.96.
TSYS (TSS) declared that it has signed a long-term renewal with U.S. Bank. As part of the agreement, TSYS will continue to support the bank’s commercial card payment services in the United States, Europe and Canada, and will also support their acquiring business.
Total System Services, Inc. provides electronic payment processing services to banks and other financial institutions in the United States, Europe, Canada, Mexico, and internationally. It operates through four segments: North America Services, International Services, Merchant Services, and NetSpend. The company offers account processing and output services, counting processing the card application, initiating service for the cardholder, processing card transaction for the issuing retailer or financial institution, and accumulating the account’s transactions.
Genetic Technologies Limited (ADR) (NASDAQ:GENE), ended its Wednesday’s trading session with 3.42% gain, and closed at $3.63.
Molecular diagnostics company Genetic Technologies Limited (GENE) declared that underpinned by a strong balance sheet, following the successful capital raise in March 2015, the Company has launched an initiative to reinvigorate the pathway to Peer Review Publication. Attaining such publications in medical journals will assist to strengthen the Company’s commercial position and accelerate reimbursement talk about with private payers. In addition, the Company plans to conduct three U.S. clinical studies and is presently in the process of preparing for the presentation of accomplished scientific validation studies.
The Company had formerly conducted multiple scientific studies to develop and validate the first generation BREVAGen™ test in addition to created two health economic models to demonstrate potential cost savings and health benefits associated with the BREVAGen test. Importantly, due to the nature of the technology and the specific improvements incorporated in BREVAGenplus®, the research undertaken and published based on the original version of the test remains applicable to the new iteration.
Genetic Technologies Limited provides genetic testing services primarily in Australia and the United States. It offers a range of genetic tests for breast and ovarian cancer, bowel and uterine cancer, and prostate cancer; neurogenetic diagnostic assays; and gene testing for Epilepsy SCN1A gene related disorders.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
